Douglas M. Singer Amends Interpace Biosciences Stake
Ticker: IDXG · Form: SC 13G/A · Filed: Feb 12, 2024 · CIK: 1054102
| Field | Detail |
|---|---|
| Company | Interpace Biosciences, Inc. (IDXG) |
| Form Type | SC 13G/A |
| Filed Date | Feb 12, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: insider-ownership, amendment, shareholder-update
Related Tickers: IDXG
TL;DR
**Singer updated his Interpace Biosciences stake as of year-end 2023.**
AI Summary
Douglas M. Singer, an individual investor, has filed an amended Schedule 13G/A for Interpace Biosciences, Inc. (NASDAQ: IDXG), indicating his beneficial ownership of the company's common stock as of December 31, 2023. This amendment, filed on February 12, 2024, updates his previous disclosures regarding his stake in the surgical and medical instruments company. This matters to investors because it provides transparency into significant shareholder positions, which can influence stock performance and corporate governance.
Why It Matters
This filing updates the public record on a significant investor's holdings, offering transparency into major shareholder activity which can signal confidence or concern in the company's future.
Risk Assessment
Risk Level: low — This is a routine amendment filing, not indicating any immediate high-risk event for the company.
Analyst Insight
Investors should note that Douglas M. Singer continues to hold a significant stake in Interpace Biosciences, as indicated by this amendment. While the filing itself doesn't reveal changes in ownership percentage, it confirms his ongoing position as of year-end 2023. Smart investors might monitor future filings from Singer for any significant changes in his holdings, which could signal his evolving view on the company's prospects.
Key Players & Entities
- Douglas M. Singer (person) — Reporting Person, beneficial owner of Interpace Biosciences, Inc. shares
- Interpace Biosciences, Inc. (company) — Subject Company, a surgical and medical instruments & apparatus firm
- December 31, 2023 (date) — Date of Event which Requires Filing of this Statement
- February 12, 2024 (date) — Date the SC 13G/A amendment was filed
FAQ
Who is the reporting person in this SC 13G/A filing?
The reporting person is Douglas M. Singer, an individual investor with a mailing address at 9833 E. Dreyfus Avenue, Scottsdale, AZ 85260.
What is the subject company of this filing?
The subject company is Interpace Biosciences, Inc., with a CIK of 0001054102 and a business address at Waterview Plaza, Suite 310, 2001 Route 46, Parsippany, NJ 07054.
What type of security is covered by this filing?
The filing covers Common Stock, $.01 par value, of Interpace Biosciences, Inc., with CUSIP Number 46062X303.
What is the 'Date of Event which Requires Filing of this Statement'?
The 'Date of Event which Requires Filing of this Statement' is December 31, 2023, as stated on the cover page of the filing.
What is the purpose of an SC 13G/A filing?
An SC 13G/A is an amendment to a Schedule 13G, used by passive investors who own more than 5% but less than 20% of a company's stock to update their beneficial ownership information, as per the Securities Exchange Act of 1934.
Filing Stats: 839 words · 3 min read · ~3 pages · Grade level 7.2 · Accepted 2024-02-12 17:01:48
Key Financial Figures
- $0.01 — of Class of Securities: Common Stock, $0.01 par value (e) CUSIP Number: 46062X
Filing Documents
- form_sc-13ga.htm (SC 13G/A) — 44KB
- 0001199835-24-000080.txt ( ) — 46KB
Ownership
Item 6. Ownership of More than Five Percent on Behalf of Another Person Not Applicable.
Identification
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not Applicable.
Identification
Item 8. Identification and Classification of Member of the Group Not Applicable.
Notice
Item 9. Notice of Dissolution of Group Not Applicable.
Certification
Item 10. Certification Not Applicable. CUSIP No. 46062X303 Page 5 of 5
Signatures
Signatures After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct. Dated: February 12, 2024 /s/ Douglas M. Singer Douglas M. Singer